ADVERTISING AND SPONSORSHIP POLICY

Editorial Independence & Revenue Principles

The Journal of Biomolecules, Pathogenesis and Therapeutics (JBPT) maintains absolute independence between its business operations, revenue streams, and its scholarly publishing choices. Advertising space or external sponsorship agreements will never be accepted under conditions where any editorial influence over peer review, manuscript selection, or publishing timelines is granted to the funding body.

Commercial Interests Do Not Influence Editorial Decisions

Content Separation & Accuracy Mandates

All advertisements, commercial messages, or sponsor disclosures displayed across the digital platform must be factually accurate, clear, and contextually distinct from the scholarly editorial content. JBPT ensures that advertising assets are presented in a layout structure that clearly differentiates them from published research papers and academic board rosters.

Prohibited Associations: JBPT explicitly prohibits any promotion, marketing, or business association with products or services that conflict with scientific research ethics, medical standards, or public health guidelines (including tobacco, weapons, or unverified medical treatments).

Final Discretion & Compliance Authority

The final discretion regarding advertising eligibility, sponsor compliance, visual placement rules, and agreement terminations rests solely and unconditionally with the JBPT Editorial Board.

Advertisements displayed on the journal's digital environment do not constitute an endorsement or validation of the product or service by the JBPT Editorial Board, the parent publisher (MSAR Institute), or any affiliated academic institutions.